The European Bioinformatics Institute: empowering cooperation in response to a global health crisis. - Gaia Cantelli; Guy Cochrane; Cath Brooksbank; Ellen M. McDonagh; Paul Flicek; Johanna R. McEntyre; Ewan Birney; Rolf Apweiler (Nucleic Acids Res., 2021)

Open Targets Genetics: systematic identification of trait-associated genes using large-scale genetics and functional genomics. - Maya Ghoussaini; Edward Mountjoy; Miguel Carmona; Gareth Peat; Ellen M. Schmidt; Andrew Hercules; Luca Fumis; Alfredo Miranda; Denise Carvalho-Silva; Annalisa Buniello; Tony Burdett; James D. Hayhurst; et al. (Nucleic Acids Res., 2021)

Open Targets Platform: supporting systematic drug-target identification and prioritisation. - David Ochoa; Andrew Hercules; Miguel Carmona; Daniel Suveges; Asier Gonzalez-Uriarte; Cinzia Malangone; Alfredo Miranda; Luca Fumis; Denise Carvalho-Silva; Michaela Spitzer; Jarrod Baker; Javier Ferrer; et al. (Nucleic Acids Res., 2021)

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt. - David Ochoa; Andrew Hercules; Miguel Carmona; Daniel Suveges; Jarrod Baker; Cinzia Malangone; Irene Lopez; Alfredo Miranda; Carlos Cruz-Castillo; Luca Fumis; Manuel Bernal Llinares; Kirill Tsukanov; et al. (Nucleic Acids Res., 2023)

EMBL's European Bioinformatics Institute (EMBL-EBI) in 2022. - Matthew Thakur; Alex Bateman; Cath Brooksbank; Mallory Ann Freeberg; Melissa Harrison; Matthew Hartley; Thomas M. Keane; Gerard J. Kleywegt; Andrew Leach; Maria Levchenko; Sarah L. Morgan; Ellen M. McDonagh; et al. (Nucleic Acids Res., 2023)